Label: GENGICURE- hyaluronic acid gel
- NDC Code(s): 82160-566-01
- Packager: Pella Pharmaceuticals Co. Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated December 6, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Forms and Presentation
- Active Ingredient
- Inactive Ingredients
- Purpose
-
Properties
gengicure® gel has a special formula immediately reduces pain and promotes the treatment of oral mucosal ulcers by accelerating normal healing process because it contains hyaluronic acid, a natural substance found in the connective tissues of the body. When applied to the ulcers it stimulates the production of new healthy tissue.
Paraben Free
Sugar Free
Colorants Free - Indication
- Precautions
- Warnings
- Contraindication
- Pregnancy and Lactation
- Interactions
- Side effects
-
Dosage and administration
Apply a film of gel onto affected area only, massaging gently with clean fingers to aid its correct distribution and then keep it to dry for 30 – 60 seconds.
Apply 2-3 times daily, for one week or until the symptoms disappear.
It is advisable not to eat or drink for at least 30 minutes after application. - Storage Conditions
- Primary Package
- Secondary Package
-
INGREDIENTS AND APPEARANCE
GENGICURE
hyaluronic acid gelProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:82160-566 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYALURONIC ACID (UNII: S270N0TRQY) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONIC ACID 0.3 mg in 15 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) DICHLOROBENZYL ALCOHOL (UNII: 1NKX3648J9) SODIUM BENZOATE (UNII: OJ245FE5EU) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:82160-566-01 1 in 1 CARTON 01/15/2020 1 15 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/15/2020 Labeler - Pella Pharmaceuticals Co. Ltd (562370925)